21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Preservation of ergothioneine
#11402NEW FORMULATIONS AND USE THEREOF
#11403MEDICAMENT COMPOSITIONS CONTAINING ANTICHOLINERGICALLY-EFFECTIVE COMPOUNDS AND BETAMIMETICS
#11404COMBINATION OF A 5HT7 RECEPTOR LIGAND AND AN OPIOID RECEPTOR LIGAND
#11405Compositions and methods for treatment of diseases and conditions with increased vascular permeability
#11406Pyrimidinyl pyridazinone derivatives
#11407(THIO) -CARBAMOYL-CYCLOHEXANE DERIVATIVES AND METHOD FOR TREATING SCHIZOPHRENIA
#11408METHOD AND COMPOSITIONS FOR TREATMENT OF PAINFUL DISORDERS
#11409COMPOSITIONS AND METHODS OF TREATMENT COMPRISING CEFTAROLINE
#11410Compositions and methods for diagnosing and treating community-acquired methicillin-resistant
#11411COMPOUNDS THAT INHIBIT OESTRONE SULPHATASE; COMPOSITIONS THEREOF; AND METHODS EMPLOYING THE SAME
#11412PHYTOCHEMICAL-RICH OILS AND METHODS RELATED THERETO
#11413SLOW RELEASE MISOPROSTOL FOR OBSTETRIC AND/OR GYNAECOLOGICAL APPLICATIONS
#11414ANTI-INFLAMMATORY DERMATOLOGICAL COMPOSITION COMPRISING CORTICOSTEROIDS AND HYALURONATE FRAGMENTS, AND USES THEREOF
#11415METHODS OF TREATING PSYCHIATRIC, SUBSTANCE ABUSE, AND OTHER DISORDERS USING COMBINATIONS CONTAINING OMEGA-3 FATTY ACIDS
#11416Anthelmintic combination
#11417THERAPEUTIC USE OF PEPTIDE YGLF AND COMBINATION WITH KVLPVPQ
#11418USE OF THE PEPTIDE HIS-SER-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE ALONE OR IN COMBINATION WITH THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS-OH AS A THERAPEUTIC AGENT
#11419TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES
#11420Modulators of the ABC transporter family and methods for their use
#114214-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
#11422USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11423USE OF SECRETIN AND OPTIONALLY URODILATIN AS THERAPEUTIC AGENTS
#11424USE OF A RGD-PEPTIDE AND/OR PARATHYROID HORMONE (1-34) AS ANTI-HIV AGENT
#11425Use of somatostatin-14 as a therapeutic agent
#11426Nanoassembled complexes of nucleic acids, avidin and polymers, use and preparation thereof
#11427Compositions containing amines and use thereof
#11428Formulation for the treatment of hypoxia and related disorders
#11429COLON CLEANSING COMPOSITIONS AND METHODS
#11430Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
#11431Treatment of Wounds and Compositions Employed
#11432SYNERGISTIC ACTIVE PREPARATIONS COMPRISING 1,2-DECANEDIOL AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS
#11433Low odor, hard surface sporicide
#11434Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#11435Compositions and methods of delivery of pharmacological agents
#11436Bone growth particles and osteoinductive composition thereof
#11437METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#11438Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
#11439Tablet dosage form
#11440METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS
#11441RESUSCITATION FLUID
#11442THERAPEUTIC FORMULATIONS CONTAINING VENOM OR VENOM ANTI-SERUM EITHER ALONE OR IN COMBINATION FOR THE THERAPEUTIC PROPHYLAXIS AND THERAPY OF NEOPLASMS
#11443MODIFIED CYTOKINES FOR USE IN CANCER THERAPY
#11444Pharmaceutical compositions and methods for treating erectile dysfunction
#11445IMPLANTS CONTAINING DISULFIRAM AND AN ANTI-INFLAMMATORY AGENT
#11446DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID ARTHRITIS BY IMPROVING SIGNS AND SYMPTOMS, SHOWING MAJOR OR COMPLETE CLINICAL RESPONSE AND BY PREVENTING FROM JOINT DAMAGE
#11447OROS PUSH-STICK FOR CONTROLLED DELIVERY OF ACTIVE AGENTS
#11448Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
#11449Silver ionized plant extraction liquid and use thereof
#11450Use of yeast flakes for treating and/or preventing hyperinsulinemia
#11451Method of suppressing disease severity of multiple sclerosis using chemokine CXC11
#11452USE OF RAPAMYCIN TO INHIBIT IMMUNE RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS
#11453Methods of using corticotropin-releasing factor for the use of the treatment of cancer
#11454Ligands of HVEM for treating hematologic malignancies
#11455Intrathecal and intratumoral superantigens to treat malignant disease
#11456FcgammaRIIB Fusion Proteins and Compositions Thereof
#11457Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#11458CANCER TREATMENT COMBINATION THERAPY COMPRISING VINFLUNINE AND TRASTUZUMAB
#11459Glutamate receptor antagonists and methods of use
#11460COMBINATION TREATMENT WITH t-PA VARIANT AND LOW MOLECULAR WEIGHT HEPARIN
#11461BONE GRAFTS WITH REDUCED PROTEASE ACTIVITY AND METHODS OF SELECTION AND USE
#11462COMPOSITIONS AND METHODS FOR TREATING PANCREATIC INSUFFICIENCY
#11463LACTID ACID BACTERIA AS PRIOBIOTIC STRAINS AND COMPOSITIONS CONTAINING SAME
#11464Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
#11465COMPOSITION FOR TREATING ISCHEMIC LIMB DISEASE COMPRISING STEM CELLS DERIVED FROM ADIPOSE TISSUE
#11466Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods
#11467Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof
#11468COMPOUNDS
#11469Cyclic undecapeptides and derivatives as multiple sclerosis therapies
#11470Modified two-component gelation systems, methods of use and methods of manufacture
#11471Modified two-component gelation systems, methods of use and methods of manufacture
#11472METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES
#11473METHODS OF TREATING CANCER BY ADMINISTERING HUMAN IL-18 COMBINATIONS
#11474VITAMIN D3 AND ANALOGS THEREOF FOR ALLEVIATING SIDE EFFECTS ASSOCIATED WITH CHEMOTHERAPY
#11475HERBAL MIXTURE EXTRACT OF PLEUROTUS ERYNGII, ACANTHOPANACIS CORTEX AND NOTOGINSENG RADIX AND A COMPOSITION COMPRISING THE SAME FOR PREVENTION AND TREATMENT OF PERIODONTITIS
#11476INHALATION DELIVERY METHODS AND DEVICES
#11477USE OF SOMATOSTATIN ANALOGS IN MYOCARDIAL PERFUSION IMAGING
#11478Bacteriostatic catheter lock containing glycerol
#11479Manipulation of ovarian primordial follicles
#11480METHODS FOR SELECTIVELY ENHANCING ANTINOCICEPTIVE POTENCY OF LOCAL ANESTHETICS
#11481Pharmaceutical formulations containing lipoic acid derivatives
#11482ORAL COMPOSITION WITH AN ANTIAGEING EFFECT ON THE SKIN
#11483COMBINATION FORMULATIONS
#11484PREPARATION FOR THE TREATMENT OF EQUINE LAMINITIS
#11485Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
#11486COMPOSITIONS FOR AFFECTING WEIGHT LOSS
#11487COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#11488Pharmaceutical Combination
#11489NOVEL COMBINATION OF NERAMEXANE FOR TREATMENT OF NERORDEGENERATIE DISORDERS
#11490GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
#11491Benzoxazole kinase inhibitors and methods of use
#11492Compositions and methods of treating viral infections
#11493Rapidly Dissolving Vitamin Formulation and Methods of Using the Same
#11494Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
#11495COMPOSITIONS COMPRISING INOSINE AND OROTIC ACID AND METHODS OF USE THEREOF FOR THE TREATMENT OF CERTAIN HEART CONDITIONS AND ENHANCEMENT OF WORK CAPACITY
#11496MORPHOLINYL ANTHRACYCLINE DERIVATIVE COMBINED WITH PROTEIN KINASE INHIBITORS
#11497SUBSTANCE P AND THYROTROPIN RELEASING HORMONE FOR THERAPEUTIC APPLICATIONS
#11498Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine
#11499TREATMENT OF T-CELL MEDIATED DISEASES
#11500Methods for identifying patients who will respond well to cancer treatment
#11501METHODS FOR REDUCING GNRH-POSITIVE TUMOR CELL PROLIFERATION
#11502Growth of bifidobacteria in fermented milk products
#11503Medicinal herbal composition for treating infection
#11504Pharmaceutical composition for treating rheumatism, and method of making same
#11505Triterpene compositions and methods for use thereof
#11506Composition and Methods for Maintaining Skeletal Muscle Androgen Receptivity
#11507NEURO-DEGENERATIVE INHIBITOR, NEURO-ENDOCRINE MODULATOR, AND NEURO-CEREBRAL METABOLISM ENHANCER
#11508Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
#11509Treating glaucoma
#11510COLON CLEANSING COMPOSITIONS AND METHODS
#11511Herbomineral formulation for treating sickle cell disease
#11512AGENT FOR TREATING AND/OR PREVENTING OSTEOPOROSIS, COMPRISING OCEANIC MINERAL COMPONENTS
#11513Amebacidal ophthalmologic compound
#11514Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
#11515Use of an ozone / oxygen mixture as a primary anticancer therapy via intraperitoneal insufflation
#11516ORAL ANTIDEPRESSANT FORMULATION
#11517ELECTROPHORETIC TRANSDERMAL DELIVERY SYSTEM
#11518IN VIVO GENE TRANSFER METHODS FOR WOUND HEALING
#11519Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
#11520Compositions comprising carisoprodol and methods of use thereof
#11521Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as Carrier
#11522Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma
#11523Compositions of TLR ligands and antivirals
#11524ANTI-KIR ANTIBODIES, FORMULATIONS, AND USES THEREOF
#11525COMPOSITIONS AND METHODS FOR RESTORING BACTERIAL FLORA
#11526IRAK-1 AS REGULATOR OF DISEASES AND DISORDERS
#11527Dose forms comprising VX-950 and their dosage regimen
#11528Modulators of pharmacokinetic properties of therapeutics
#11529Use of gp130 activators in diabetic neuropathy
#11530Pulsatile Dosing of Gossypol for Treatment of Disease
#11531Methods of Using Phosphoantigens Together with Interleukin-2 for the Treatment of Cancer
#11532Regulation of mammalian keratinous tissue using skin and/or hair care actives
#11533Composition for treating herpes simplex viral infections, the method, use and process by which the composition is utilized and the manufacture of the composition
#11534Pyrone analogs for therapeutic treatment
#11535Systems, devices, and methods for making or administering frozen particles
#11536PERITONEAL DIALYSATE
#11537Systems, devices, and methods for making or administering frozen particles
#11538Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
#11539Inhibition of Bacterial Protein Production by Polyvalent Oligonucleotide Modified Nanoparticle Conjugates
#11540COMBINATIONS COMPRISING STAUROSPORINES
#11541Methods of treating neuropathy
#11542Methods to inhibit tumor cell growth by using proton pump inhibitors
#11543MODULATION OF NEUROGENESIS BY PPAR AGENTS
#11544Compositions incorporating sesamin-class compounds and vitamin B1 class compounds
#11545PHARMACEUTICAL COMPOSITIONS COMPRISING A MULTIFUNCTIONAL PHOSPHODIESTERASE INHIBITOR AND AN ADENOSINE UPTAKE INHIBITOR
#11546COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY ATHEROSCLEROSIS COMPRISING A MAST CELL INHIBITOR AND A PPAR GAMMA AGONIST
#11547Benzoxazole kinase inhibitors and methods of use
#11548QUINOLINONE DERIVATIVES
#11549USE OF CHOLINESTERASE INHIBITORS FOR TREATING VASCULAR DEPRESSION
#11550Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
#11551New Pharmaceutical Compositions for Treatment of Thrombosis
#11552Methods for treatment for ulcerative colitis in mammals
#11553Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#11554Treatment of statin side effects using uridine derivatives
#11555USE OF GLY-PRO-GLU-OH (GPE) AS A THERAPEUTIC AGENT
#11556Anticonvulsive pharmaceutical compositions
#11557T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR CANCER THERAPY
#11558Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation
#11559Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications
#11560SYSTEMS AND METHODS FOR TREATING POST- OPERATIVE, ACUTE, AND CHRONIC PAIN USING AN INTRA-MUSCULAR CATHETER ADMINISTRATED COMBINATION OF A LOCAL ANESTHETIC AND A NEUROTOXIN PROTEIN
#11561THERAPEUTIC USES OF B-TYPE NATRIURETIC PEPTIDE AND HUMAN GROWTH HORMONE 1-43
#11562USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11563USE OF THE HUMAN PANCREATIC POLYPEPTIDE AS A THERAPEUTIC AGENT
#11564USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11565USE OF GLUCAGON (1-29) ALONE OR IN COMBINATION WITH NEUROPEPTIDE W30 AS A THERAPEUTIC AGENT
#11566PROADRENOMEDULLIN ALONE OR IN COMBINATION WITH BIG GASTRIN I AS A THERAPEUTIC AGENT
#11567Method for screening a test substance for activating a receptor associated with FGF 21 activity
#11568OPHTHALMIC COMPOSITIONS USEFUL FOR IMPROVING VISUAL ACUITY
#11569MUCOSAL REPAIR BY TFF DIMER PEPTIDES
#11570TOPICALLY ACTIVE STEROIDS FOR USE IN RADIATION AND CHEMOTHERAPEUTICS INJURY
#11571DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE
#11572Potent inhibitory effect of zinc in combination with sulforaphane on cancer cell growth
#11573Nanoparticle comprising rapamycin and albumin as anticancer agent
#11574MULTIPLE ACTIVE PHARMACEUTICAL INGREDIENTS COMBINED IN DISCRETE INHALATION PARTICLES AND FORMULATIONS THEREOF
#11575Hydrogel of chitosan carboxyalkylamide, preparation thereof and cosmetic and dermatological use thereof
#11576Surgical applications for BMP binding protein
#11577COMPOSITIONS AND TREATMENT OF HEART DEFICIENCY IN NON-HUMAN ANIMALS
#11578TABLETED COMPOSITIONS CONTAINING ATAZANAVIR
#11579Formulation
#11580Methods and compositions for treating HIV infection
#11581Method to maintain the efficacy of orlistat
#11582Tumor and infectious disease therapeutic compositions
#11583and composition and uses thereof
#11584Fully human antibodies against human 4-1BB
#11585PREVENTIVE/REMEDY FOR CANCER
#11586Combination of Aurora Kinase Inhibitors and Anti-CD20 Antibodies
#11587METHODS OF TREATING CARDIOVASCULAR DISORDERS
#11588STEROID-SPARING METHODS OF TREATING BRAIN EDEMA
#11589HUMAN EPO RECEPTOR AGONISTS, COMPOSITIONS, METHODS AND USES FOR PREVENTING OR TREATING GLUCOSE INTOLERANCE RELATED CONDITIONS
#11590Methods for reducing corneal nerves damage, corneal lymphangiogenesis or immunity to corneal antigens in dry-eye associated ocular surface diseases by IL-1Ra
#11591CELL CAPABLE OF EXPRESSING LACRITIN AT HIGH LEVEL
#11592Biological therapeutic compositions and methods thereof
#11593Angiogenesis-modulating compositions and uses
#11594Composition and Methods for Affecting Metallocorrinoid Uptake
#11595TARGETED CARGO PROTEIN COMBINATION THERAPY
#11596METHOD FOR THE TREATMENT OF RADIATION-INDUCED NEUTROPENIA BY ADMINISTRATION OF A MULTI-PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) VARIANT
#11597Synergism Between Activated Immune Cells and Conventional Cancer Therapies
#11598Methods of Treating Autoimmune Diseases
#11599Acne treatment powder foundation
#11600ANTIOXIDANT COMPOSITIONS FOR SOFT ORAL TISSUE AND METHODS OF FORMULATION AND USE THEREOF
#11601Topical Poloxamer Formulations for Enhancing Microvascular Flow: Compositions and Uses Thereof
#11602Myocardial perfusion imaging methods and compositions
#11603Compositions comprising bile acid sequestrants for treating esophageal disorders
#11604AMPA Receptor Antagonists and Zonisamide for Neuropathic Pain
#11605USE OF PKC INHIBITORS IN OCULAR DISEASES
#11606Pharmacological treatment of Parkinson's disease
#11607Methods for concomitant administration of colchicine and a second active agent
#11608NOL3 is a predictor of patient outcome
#11609Pharmaceutical combinations
#11610Cancer Combination Therapy Comprising AZD2171 and ZD1839
#11611Carboline derivatives useful in the inhibition of angiogenesis
#11612COMPOSITIONS OF AN ANTICONVULSANT AND MIRTAZAPINE TO PREVENT WEIGHT GAIN
#11613Stanol composition and the use thereof
#11614Nutritional intervention for improving muscular function and strength
#11615SYNTHETIC NUTRITIONAL FORMULATIONS
#11616USE OF FOLATES FOR PRODUCING A PREPARATION SUITABLE FOR PREVENTING AND TREATING INFLAMMATION AND DISEASES ASSOCIATED WITH INFLAMMATION, ESPECIALLY FOR INFLUENCING THE INFLAMMATION MARKERS CRP AND SAA
#11617Treatment of Conditions Related to Shock
#11618Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly
#11619TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF
#11620Hair follicle graft from tissue engineered skin
#11621Food-based Supplement Delivery System
#11622COMPOSITION FOR SUPRESSING APPETITE, IMPROVING TONE AND MOOD, WITH A NATURAL ANTIDEPRESSANT ACTIVITY AND WITH AN ANTIASTHENIC EFFECT
#11623Herbal formulation for wound healing
#11624Dietary supplements against latent foreign DNA
#11625Agent for preventing bleeding from cerebral cortical vein
#11626NUTRITIVE COMPOSITION
#11627METHOD FOR IN SITU SOLIDIFICATION OF BLOOD-POLYMER COMPOSITIONS FOR REGENERATIVE MEDICINE AND CARTILAGE REPAIR APPLICATIONS
#11628Remedy
#11629TABLETED COMPOSITIONS CONTAINING ATAZANAVIR
#11630TABLETED COMPOSITIONS CONTAINING ATAZANAVIR
#11631AMPHIPHILIC NUCLEOTIDE COCHLEATE COMPOSITIONS AND METHODS OF USING THE SAME
#11632Dermal Delivery Device
#11633METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES
#11634Means and methods for the recruitment and identification of stem cells
#11635USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER'S DISEASE
#11636Use of extracts or fractions against 5-lipoxygenase mediated diseases
#11637USE OF COAGULATION PROTEINS TO LYSE CLOTS
#11638SYNERGISTIC ANTHELMINTIC COMPOSITION
#11639Supplemention of maternal diet
#11640METHODS AND COMPOSITIONS FOR TREATING MUCOSITIS
#11641Combination Therapy
#11642COMPOSITION AND METHOD FOR THE TREATEMENT OF SKIN IRRITATIONS
#11643Composition and method to treat otitis media and ventilator- associated pneumonia
#11644BUFFERED COMPOSITIONS FOR DIALYSIS
#11645SYNERGISTIC MIXTURES OF OPP AND DGH
#11646ANTIVIRAL OLIGONUCLEOTIDES TARGETING RSV
#11647Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer
#11648The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
#11649Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
#11650TREATMENT OF CANCERS HAVING RESISTANCE TO CHEMOTHERAPEUTIC AGENTS
#11651Nerve cell death inhibitor
#11652Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system-related disorders
#11653COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
#11654HARMINE DERIVATIVES FOR REDUCING BODY WEIGHT
#11655Antiretroviral Solid Oral Composition
#11656Bicyclic amide derivatives for the treatment of respiratory disorders
#11657Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
#11658Bactericidal anti-MRSA active pharmaceutical composition containing carbapenems
#11659COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#11660Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#11661TREATMENT OF SURFACTANTS
#11662Composition and method for healing tissues
#11663Synergistic antiviral compositions comprising a viral attachment inhibitor, integration inhibitor, and proviral transcription inhibitor
#11664Purifications of pomegranate ellagitannins and their uses thereof
#11665METHODS OF PRODUCING AND USING NUTRITIONAL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE ACTIVE SUBSTANCES
#11666Dermatalogical formulations
#11667USE OF FERTIRELIN AND DELTA-ENDORPHIN AS THERAPEUTIC AGENTS
#11668ANTICANCEROUS POLYMERIC AGENTS
#11669Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof
#11670METHODS AND COMPOSITIONS FOR ALTERING HEALTH, WELLBEING, AND LIFESPAN
#11671Medical herb composition for inhibiting shedding of a mammal's hair and method for preparing the same
#11672COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS AND METABOLIC SYNDROME
#11673Methods for inhibiting sensory responses in the skin such as pain and itch using topical product formulations containing strontium
#11674TREATMENT OF NEOPLASTIC DISORDERS USING COMBINATION THERAPIES
#11675DISINFECTANT CLEANING COMPOSITION AND METHOD
#11676Polymetaphosphate based formulations for therapy of microcrystalline arthropathies
#11677COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS IN MAMMALS
#11678METHODS OF RESTORATION OF ERECTILE FUNCTION
#11679Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
#11680Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
#11681TABLET DOSAGE FORM COMPRISING CETIRIZINE AND PSEUDOEPHEDRINE
#11682Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole
#11683Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
#11684Pharmaceutical composition
#11685ANTIVIRAL OLIGONUCLEOTIDES TARGETING VIRAL FAMILIES
#11686Enhanced Medical Implant
#11687Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
#11688Treating neoplasms with neurotoxin
#11689ENVELOPED VIRUS NEUTRALIZING COMPOUNDS
#11690Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
#11691Method of inducing immune tolerance to type I diabetes
#11692SUBSTITUTED HYDROXYPHENYLAMINE COMPOUNDS
#11693HMG1 antibody for treating inflammatory conditions
#11694Combination of an anti-EP-CAM antibody with a chemotherapeutic agent
#11695Use of reversine and analogs for treatment of cancer
#11696STRAINS AND METHODS FOR IMPROVING RUMINANT HEALTH AND/OR PERFORMANCE
#11697Combination therapy for the treatment of HCV infection
#11698METHODS OF ENHANCING HAIR GROWTH
#11699Enhanced medical implant comprising disrupted tooth pulp and tooth particles
#11700Anionic Polymers as Toxin Binders and Antibacterial Agents